Introduction. The purpose of this study was to evaluate the application of the Dmax method on heart rate variability (HRV) to estimate the lactate thresholds (LT), during a maximal incremental running test (MIRT). Methods. Nineteen male runners performed two MIRTs, with the initial speed at 8 km·h−1 and increments of 1 km·h−1 every 3 minutes, until exhaustion. Measures of HRV and blood lactate concentrations were obtained, and lactate (LT1 and LT2) and HRV (HRVTDMAX1 and HRVTDMAX2) thresholds were identified. ANOVA with Scheffe’s post hoc test, effect sizes (d), the bias ± 95% limits of agreement (LoA), standard error of the estimate (SEE), Pearson’s (r), and intraclass correlation coefficient (ICC) were calculated to assess validity. Results. No significant differences were observed between HRVTDMAX1 and LT1 when expressed for speed (12.1 ± 1.4 km·h−1 and 11.2 ± 2.1 km·h−1; ; d = 0.45; r = 0.46; bias ± LoA = 0.8 ± 3.7 km·h−1; SEE = 1.2 km·h−1 (95% CI, 0.9–1.9)). Significant differences were observed between HRVTDMAX2 and LT2 when expressed for speed (12.0 ± 1.2 km·h−1 and 14.1 ± 2.5 km·h−1; ; d = 1.21; r = 0.48; bias ± LoA = −1.0 ± 1.8 km·h−1; SEE = 1.1 km·h−1 (95% CI, 0.8–1.6)), respectively. Reproducibility values were found for the LT1 (ICC = 0.90; bias ± LoA = −0.7 ± 2.0 km·h−1), LT2 (ICC = 0.97; bias ± LoA = −0.1 ± 1.1 km·h−1), HRVTDMAX1 (ICC = 0.48; bias ± LoA = −0.2 ± 3.4 km·h−1), and HRVTDMAX2 (ICC = 0.30; bias ± LoA = 0.3 ± 3.5 km·h−1). Conclusions. The Dmax method applied over a HRV dataset allowed the identification of LT1 that is close to aerobic threshold, during a MIRT.
24 September 2024 in European Journal of Applied Physiology
The purpose of this study was to verify the heart rate variability (HRV) and heart rate (HR) kinetics during the fundamental phase in different intensity domains of cycling exercise. Fourteen males performed five exercise sessions: (1) maximal incremental cycling test; (2) two rest‐to‐exercise transitions for each intensity domain, that is, heavy (Δ30) and severe (Δ60) domains. HRV markers (SD1 and SD2) and HR kinetics in the fundamental phase were analyzed by first‐order exponential fitting. There were no significant differences in amplitude values between SD1Δ30 (8.98 ± 3.52 ms) and SD1Δ60 (9.44 ± 3.24 ms) and SD2Δ30 (24.93 ± 9.16 ms) and SD2Δ60 (25.98 ± 7.29 ms). Significant difference was observed between HRΔ30 (52 ± 7 bpm) and HRΔ60 (63 ± 8 bpm). The time constant (τ) values were significantly different between SD1Δ30 (17.61 ± 6.26 s) and SD1Δ60 (13.86 ± 5.90 s), but not between SD2Δ30 (20.06 ± 3.73 s) and SD2Δ60 (19.47 ± 6.03 s) or HRΔ30 (56.75 ± 18.22 s) and HRΔ60 (58.49 ± 15.61 s). However, the τ values for HRΔ30 were higher and significantly different in relation to SD1Δ30 and SD2Δ30, as well as for HRΔ60 in relation to SD1Δ60 and SD2Δ60. The kinetics of the autonomic variable (SD1 marker) was accelerated by the increased intensity. Moreover, significant differences were found for the τ values, with faster HRV markers than HR, in both intensities of Δ30 and Δ60, which suggests that these variables indicate distinct and specific cardiac autonomic response times during different intensity domains in cycling.HIGHLIGHTS The application of HRV to optimize exercise prescription at different effort intensities is extremely important to obtain assertive and effective results. Analysis of the kinetic responses of HRV is a useful tool for the evaluation of exercise performance and health status. A faster kinetics was found for HRV markers in comparison to HR, for both intensities analysed, which suggests that these variables indicate distinct and specific cardiac autonomic response times during different intensity domains in cycling.
6 February 2024 in Research Quarterly for Exercise and Sport
Purpose: This study aimed to compare the performance-derived parameters utilizing isolinear (ISOLIN) and isovelocity (ISOVEL) sprint cycling modes. Method: For that, 20 male trained cyclists performed 2 sprints of 7 s on an electromagnetically braked cycle ergometer in ISOLIN and six sprints in ISOVEL mode with cadences between 90 and 180 rpm, each separated by 3-min. A linear function modeled the sprints within each mode to extrapolate maximal cadence (CMAX) and torque (TMAX), and a quadratic function was used to extrapolate the apex defined as optimal cadence power (OPTCAD) and peak power output (PMAX). Fifteen subjects performed another 4 sprints at ISOLIN mode on different days to verify the reliability. Results: The measures from the power-cadence relationship were not different between the ISOLIN and ISOVEL modes. Although significant differences were detected in the T-C relationship, TMAX was greater at ISOLIN than ISOVEL (p = .006). On the other hand, CMAX was higher at ISOVEL than ISOLIN (p < .001). The correlation between parameters was large to very large (r = 0.51 to 0.89). However, high limits of agreement were verified. The ISOLIN presented consistency during the trials, and the random errors were acceptable (CV = 5.3% to 11.5%). Conclusion: Using the power-cadence relationship, PMAX and OPTCAD could be detected similarly between the two sprint modes (ISOLIN and ISOVEL). Thus, the findings demonstrated that a single ISOLIN sprint test could be a suitable tool for quantifying the time course of muscle fatigue during and after cycling exercises in well-trained male cyclists.
1 November 2024 in International Journal of Sport Nutrition and Exercise Metabolism
This study aimed to investigate the effects of caffeine ingestion by chewing gum (GUMCAF) combined with priming exercise on pulmonary oxygen uptake () and near-infrared spectroscopy-derived muscle oxygen extraction (HHb + Mb) kinetics during cycling performed in a severe-intensity domain. Fifteen trained cyclists completed four visits: two under a placebo gum (GUMPLA) and two under GUMCAF ingestion. Each visit consisted of two square-wave cycling bouts at Δ70 intensity (70% of difference between the at first ventilatory threshold and ) with duration of 6 min each and 5 min of passive rest between the bouts. The GUMPLA or GUMCAF (400 mg) was chewed for 5 min, 12 min before the first Δ70 bout in a randomized double-blind procedure. The fundamental phase and slow component of HHb + Mb and kinetics were evaluated. For HHb + Mb kinetics, regardless of ingested gum, priming exercise effects occurred on the time constant (GUMCAF 16.0 ± 4.0 vs. 13.9 ± 2.9 s; GUMPLA 15.7 ± 6.1 vs. 13.2 ± 2.5 s), amplitude, slow component, time delay, and mean response time parameters (p ≤ .032). For kinetics, there were significant effects of bouts on the amplitude, slow component, end , and the gain kinetics parameters (p < .017). Baseline was higher during GUMCAF than GUMPLA (p = .020). No significant effects occurred for the interaction between gum and bout in any parameter of or HHb + Mb kinetics. Therefore, unlike the priming exercise in severe-intensity exercise, GUMCAF is not an effective strategy for improving or HHb + Mb kinetics acceleration.
24 March 2026 in Research Quarterly for Exercise and Sport
This study aimed to compare different thresholds obtained from the muscle near-infrared spectroscopy (NIRS), heart rate variability (HRV), HR and ventilatory parameters during a maximal incremental cycling test. Twenty trained male cyclists performed an incremental step test with breath-by-breath gas analysis, muscle NIRS-derived signal, HRV and HR continuously recorded. The first and second ventilatory thresholds (VT1 and VT2, respectively) were identified and compared to the other methods. The DMAX method was used to determine the NIRS-derived thresholds by oxygenated hemoglobin (O2HbT), deoxygenated hemoglobin (HHbT), tissue saturation index (TSIT); HRV-derived thresholds by standard deviation of the instantaneous (SD1T) and continuous long-term RR intervals (SD2T) and HR deflection point. No significant differences were found between VT1 and O2HbT (171 ± 25 vs 179 ± 46 W; SEE = 23.0 W), VT1 and SD1T (171 ± 39 W; SEE = 26.2 W) and VT1 and SD2T (185 ± 37 W; SEE = 21.7 W); as well as between VT2 and TSIT (242 ± 28 vs 230 ± 61 W; SEE = 25.1 W), when expressed as power-output, respectively. The standard error of estimate for these comparisons is approximately equivalent to one incremental stage (25 W). However, agreement analysis showed substantial inter-individual error (LoA up to ±107 W). This wide variability limits their precision for individual prescription, suggesting these methods should complement rather than substitute ventilatory thresholds.